Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
PRR11 antisense RNA 1 (PRR11-AS1) is a long non-coding RNA (lncRNA) gene located on human chromosome 17, known primarily for its regulatory role in gene expression, especially at the PRR11 locus[3][4][5]. It is also referred to as AC099850.3, AC099850.4, lnc-SKA2-1, and CTD-2510F5.4. PRR11-AS1 is associated with certain cancers, including lung cancer and hepatocellular carcinoma, where its altered expression correlates with tumor cell proliferation and invasion[3][6]. No small-molecule drugs or approved therapeutic agents target PRR11-AS1 directly, and it is not currently considered a canonical therapeutic target such as a receptor, enzyme, or transporter. Its main categorization is as a regulatory lncRNA, and it serves as a candidate for cancer research, but not as a direct drug target[3][5][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on PRR11 antisense RNA 1 (PRR11-AS1).